We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.01%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.4B
AUM Growth
+$1.27B
(+6.3%)
Cap. Flow
+$730M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
26.79%
Holding
881
New
137
Increased
443
Reduced
202
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AngloGold Ashanti
AU
|
+$259M |
| 2 |
Vale
VALE
|
+$83M |
| 3 |
WPX
WPX Energy, Inc.
WPX
|
+$44.4M |
| 4 |
Gold Fields
GFI
|
+$39.7M |
| 5 |
Royal Gold
RGLD
|
+$35.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$109M |
| 2 |
Newmont
NEM
|
+$96M |
| 3 |
B
Barrick Mining
B
|
+$77.1M |
| 4 |
Franco-Nevada
FNV
|
+$63.2M |
| 5 |
GG
Goldcorp Inc
GG
|
+$58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 50.75% |
| 2 | Energy | 16.94% |
| 3 | Healthcare | 6.45% |
| 4 | Technology | 5.96% |
| 5 | Consumer Staples | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
226
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.9M | 0.05% |
164,106
+28,925
| +21% | +$1.66M |
|
227
Walmart Inc
WMT
$871B
| $10.8M | 0.05% |
377,784
+164,298
| +77% | +$4.67M |
|
|
NEE.PRQ
228
DELISTED
NextEra Energy, Inc.
NEE.PRQ
| $10.7M | 0.05% |
143,629
+7,861
| +6% | +$565K |
|
229
Universal Display
OLED
$3.71B
| $10.6M | 0.05% |
+123,375
| New | +$11.8M |
|
230
Charles River Laboratories
CRL
$10.9B
| $10.5M | 0.05% |
93,676
+13,291
| +17% | +$1.44M |
|
231
AGCO
AGCO
$8.78B
| $10.4M | 0.05% |
171,980
+6,322
| +4% | +$404K |
|
232
Tesla
TSLA
$1.24T
| $9.82M | 0.05% |
429,405
+8,835
| +2% | +$180K |
|
233
Rithm Capital
RITM
$5.09B
| $9.41M | 0.04% |
537,838
+21,575
| +4% | +$379K |
|
234
ICL Group
ICL
$6.81B
| $9.27M | 0.04% |
2,014,048
+579,976
| +40% | +$2.66M |
|
235
United Therapeutics
UTHR
$26.3B
| $9.2M | 0.04% |
81,292
+17,203
| +27% | +$1.89M |
|
|
VEDL
236
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $9.13M | 0.04% |
671,190
-7,663
| -1% | -$123K |
|
237
Nektar Therapeutics
NKTR
$2.39B
| $9.12M | 0.04% |
12,444
+972
| +8% | +$1.12M |
|
238
Nuveen Quality Municipal Income Fund
NAD
$2.71B
| $8.9M | 0.04% |
669,405
+86,329
| +15% | +$1.14M |
|
|
HES.PRA
239
DELISTED
Hess Corporation
HES.PRA
| $8.89M | 0.04% |
117,979
+6,455
| +6% | +$439K |
|
240
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.36B
| $8.86M | 0.04% |
680,777
+92,355
| +16% | +$1.19M |
|
241
Starwood Property Trust
STWD
$6.12B
| $8.84M | 0.04% |
407,188
+12,798
| +3% | +$275K |
|
242
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.65B
| $8.8M | 0.04% |
603,427
+77,502
| +15% | +$1.14M |
|
243
iShares Russell 1000 Growth ETF
IWF
$122B
| $8.78M | 0.04% |
244,296
-15,724
| -6% | -$555K |
|
244
iShares Russell 1000 Value ETF
IWD
$82B
| $8.75M | 0.04% |
72,113
+25,475
| +55% | +$3.1M |
|
245
TJX Companies
TJX
$170B
| $8.74M | 0.04% |
183,676
+108,226
| +143% | +$4.75M |
|
|
IGEM
246
DELISTED
VanEck Vectors EM Investment Grade + BB Rated USD Sovereign Bond ETF
IGEM
| $8.45M | 0.04% |
363,000
-22,000
| -6% | -$518K |
|
247
Eaton
ETN
$157B
| $8.36M | 0.04% |
111,826
-1,520
| -1% | -$118K |
|
|
CTLT
248
DELISTED
CATALENT, INC.
CTLT
| $8.34M | 0.04% |
199,069
-9,325
| -4% | -$377K |
|
|
DRD
249
DRDGold
DRD
$1.82B
| $8.26M | 0.04% |
3,252,112
+122,548
| +4% | +$322K |
|
250
Golub Capital BDC
GBDC
$3.33B
| $8.23M | 0.04% |
459,269
+9,317
| +2% | +$166K |
|
Similar funds
DAM
VanEck Associates's Q2 2018 Portfolio in Review
As of Q2 2018, VanEck Associates held 881 positions worth $21.4B, up 6.3% from $20.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
VanEck Associates deployed $730M of net new capital in Q2 2018, opening 137 new positions and adding to 443 existing holdings. Its largest new stake was Colgate-Palmolive: 345,613 shares worth $22.4M.
By sector, the portfolio is most concentrated in Materials at 51% of assets, down from 52% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Newmont, an estimated $96M trimmed.
- VanEck Associates's largest Q2 2018 buy was Colgate-Palmolive: 345,613 shares worth $22.4M.
- VanEck Associates added most to AngloGold Ashanti in Q2 2018, an estimated $259M increase.
- VanEck Associates's biggest Q2 2018 reduction was Newmont, cutting an estimated $96M.
- VanEck Associates fully exited Monsanto Co in Q2 2018, selling an estimated $109M.
- VanEck Associates's ten largest holdings make up 27% of its $21.4B portfolio in Q2 2018.
- VanEck Associates opened 137 new positions and closed 30 in Q2 2018.
- VanEck Associates's portfolio value rose 6.3% quarter-over-quarter to $21.4B.
Based on VanEck Associates's 13F filing for Q2 2018, filed 13 Aug 2018.